Verve Therapeutics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-4,526	-3,706	4,878	4,140
Depreciation & Amortization	2,824	2,722	2,353	1,561
Loss (Gain) From Sale of Assets	-	-	-	-1,664
Asset Writedown & Restructuring Costs	-	-	-	14
Loss (Gain) From Sale of Investments	-98.72	-82.86	-39.92	-15.55
Loss (Gain) on Equity Investments	1.68	0.85	-	-
Stock-Based Compensation	373.95	258.54	13.83	287.75
Provision & Write-off of Bad Debts	-23.66	13.08	11.31	35.39
Other Operating Activities	140.88	-559.5	264.61	339.94
Change in Accounts Receivable	4,850	3,808	2,684	-2,794
Change in Inventory	-1,367	-921.09	-365.79	-845.55
Change in Accounts Payable	-3,917	-3,016	-1,204	1,055
Change in Other Net Operating Assets	-2,771	-2,236	-358.09	-482.95
Operating Cash Flow	-4,514	-3,720	8,236	1,630
Operating Cash Flow Growth	-	-	405.32%	-
Capital Expenditures	-23,442	-19,279	-27,262	-10,782
Sale of Property, Plant & Equipment	199	199	-	5,516
Sale (Purchase) of Intangibles	-41.2	-59.75	-420.08	-5.27
Investment in Securities	2,319	578.12	-3,089	-110
Other Investing Activities	3.53	-17.93	-213.99	38
Investing Cash Flow	-20,962	-18,579	-30,985	-5,343
Short-Term Debt Issued	-	2,711	-	4,300
Long-Term Debt Issued	-	31,420	10,000	3,206
Total Debt Issued	42,934	34,130	10,000	7,506
Short-Term Debt Repaid	-	-1,507	-4,300	-2,442
Long-Term Debt Repaid	-	-15,499	-4,709	-2,656
Total Debt Repaid	-18,810	-17,006	-9,009	-5,098
Net Debt Issued (Repaid)	24,124	17,124	991.02	2,408
Issuance of Common Stock	1,150	779.76	26,228	733.15
Financing Cash Flow	25,274	17,904	27,219	3,142
Foreign Exchange Rate Adjustments	108.14	94.71	-6.48	-0.72
Miscellaneous Cash Flow Adjustments	0	-	-0	-0
Net Cash Flow	-94.21	-4,300	4,464	-572.44
Free Cash Flow	-27,956	-22,999	-19,026	-9,152
Free Cash Flow Margin	-89.44%	-71.00%	-40.32%	-23.80%
Free Cash Flow Per Share	-1415.05	-1172.02	-957.66	-509.30
Cash Interest Paid	882.46	1,089	537.77	494.04
Cash Income Tax Paid	244.92	309.12	384.82	552.32
Levered Free Cash Flow	-29,567	-19,997	-20,721	-
Unlevered Free Cash Flow	-28,918	-19,572	-20,390	-
Change in Net Working Capital	5,761	649.81	-1,511	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.